Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Miguel Angel Gomez-Guijosa"'
Autor:
José Carlos Jaime-Pérez, Leticia Alejandra Olguín-Ramírez, Nereida Méndez-Ramírez, Fernando García-Rodríguez, Miguel Angel Gomez-Guijosa, Olga G. Cantú-Rodríguez, Homero Gutiérrez-Aguirre, Álvaro Gómez-Peña, Rosario Salazar-Riojas, Sylvia Aide Martínez-Cabriales, David Gómez-Almaguer
Publikováno v:
Journal of Clinical Apheresis.
Objective The influence of CD34+ cell dose on the outcome of allogeneic peripheral blood stem cell (PBSC) transplantation after reduced intensity conditioning (RIC) remains controversial. The impact of the number of CD34+ hematoprogenitors infused on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78e7379f2cef94a4f513fb5ab25c025f
https://doi.org/10.1002/jca.21278
https://doi.org/10.1002/jca.21278
Autor:
David Gómez-Almaguer, Olga G. Cantú-Rodríguez, Omar D. Borjas-Almaguer, Miguel Angel Gomez-Guijosa, César Homero Gutiérrez-Aguirre, Consuelo Mancías-Guerra, Oscar González-Llano, Luz Tarin, Manuel Solano-Genesta, José Carlos Jaime-Pérez
Publikováno v:
Haematologica. 97(5)
Background Chronic graft- versus -host disease is a common late complication of allogeneic hematopoietic stem cell transplantation. Corticosteroids are the standard initial treatment. Second-line treatment has not been well defined. We evaluated the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::912053457b8dbd8417447e22d8e62635
https://pubmed.ncbi.nlm.nih.gov/22133770
https://pubmed.ncbi.nlm.nih.gov/22133770
Autor:
Luis Pita-Ramirez, Miguel-Angel Gomez-Guijosa, Sonia Hernandez-Rodriguez, Sergio Cuin-Macedo, Gregorio Campos-Cabrera, Maria-Luisa Pedraza-Colin, Salvador Campos-Cabrera, Alicia Rivera-Trujillo, Jose-Luis Campos-Villagomez, Maria Mora-Torres, Virgina Campos-Cabrera
Publikováno v:
Blood. 126:5269-5269
Background: chronic lymphocytic leukemia (CLL) is a rare disease in Mexican mestizos (Br J Haematol 2015;169:909-911 and Int J Hematol 1999;69:253-255). No significant data on epidemiology is available. Methods: epidemiological data from samples refe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb69b6d15b5fc801df1d5fbdc7160070
https://doi.org/10.1182/blood.v126.23.5269.5269
https://doi.org/10.1182/blood.v126.23.5269.5269
Autor:
Salvador Campos-Cabrera, Gregorio Campos-Cabrera, Miguel-Angel Gomez-Guijosa, Sonia Hernandez-Rodriguez, Maria-Luisa Pedraza-Colin, Luis Pita-Ramirez, Maria Mora-Torres, Alicia Rivera-Trujillo, Jose-Luis Campos-Villagomez, Virgina Campos-Cabrera
Publikováno v:
Blood. 120:4829-4829
Abstract 4829 Introduction: Medical indication of flow cytometric immunophenotyping includes diagnosis, classification, prognosis and disease monitoring. This is an important tool that each time is more used in hematology. Third world countries could
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12417bf441a61119d2088de25ded9550
https://doi.org/10.1182/blood.v120.21.4829.4829
https://doi.org/10.1182/blood.v120.21.4829.4829
Autor:
Miguel Angel Gomez-Guijosa, David Gómez-Almaguer, Cesar Homero Gutierrez-Aguilar, José Carlos Jaime-Pérez, Manuel Solano-Genesta, Olga G. Cantú-Rodríguez, Luz Tarín-Arzaga
Publikováno v:
Blood. 114:4458-4458
Abstract 4458 Introduction The combination of rituximab and alemtuzumab have been used to treat CLL. This combination is feasible without excessive toxicity. Both antibodies have been used as monotherapy for the treatment of autoimmune diseases, incl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69bf21b182346c390fde129641d9664f
https://doi.org/10.1182/blood.v114.22.4458.4458
https://doi.org/10.1182/blood.v114.22.4458.4458
Autor:
Francisco Alejandro Lagunas-Rangel, Venice Chávez-Valencia, Miguel Ángel Gómez-Guijosa, Carlos Cortés-Penagos
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 11, Iss 4 (2016)
Acute myeloid leukemia (AML) is a group of hematological diseases, phenotypic and genetically heterogeneous, characterized by abnormal accumulation of blast cells in the bone marrows and peripheral blood. Its incidence rate is approximately 1.5 per 1
Externí odkaz:
https://doaj.org/article/6699a0b970c84333a3ee9eb7d03a6b3f